165 related articles for article (PubMed ID: 29394136)
1. EGFR expression in circulating tumor cells from high-grade metastatic soft tissue sarcomas.
Braun AC; de Mello CAL; Corassa M; Abdallah EA; Urvanegia AC; Alves VS; Flores BCTCP; Díaz M; Nicolau UR; Silva VSE; Calsavara V; Paterlini-Brechót P; Chinen LTD
Cancer Biol Ther; 2018 Jun; 19(6):454-460. PubMed ID: 29394136
[TBL] [Abstract][Full Text] [Related]
2. CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.
Torres JA; Brito ABC; Silva VSE; Messias IM; Braun AC; Ruano APC; Buim MEC; Carraro DM; Chinen LTD
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569332
[TBL] [Abstract][Full Text] [Related]
3. Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion.
Chinen LT; Mello CA; Abdallah EA; Ocea LM; Buim ME; Breve NM; Gasparini JL; Fanelli MF; Paterlini-Bréchot P
Onco Targets Ther; 2014; 7():1609-17. PubMed ID: 25258541
[TBL] [Abstract][Full Text] [Related]
4. High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness.
Long E; Ilie M; Bence C; Butori C; Selva E; Lalvée S; Bonnetaud C; Poissonnet G; Lacour JP; Bahadoran P; Brest P; Gilson E; Ballotti R; Hofman V; Hofman P
Cancer Med; 2016 Jun; 5(6):1022-30. PubMed ID: 26945789
[TBL] [Abstract][Full Text] [Related]
5. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
[TBL] [Abstract][Full Text] [Related]
6. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
7. Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients.
Ilie M; Szafer-Glusman E; Hofman V; Long-Mira E; Suttmann R; Darbonne W; Butori C; Lalvée S; Fayada J; Selva E; Yu W; Marquette CH; Shames DS; Punnoose E; Hofman P
Oncotarget; 2017 Apr; 8(16):26112-26121. PubMed ID: 28212540
[TBL] [Abstract][Full Text] [Related]
8. Identification of Aneuploid Circulating Tumor Cells in Soft-Tissue Sarcoma Patients: A Pilot Study.
Napolitano A; Minelli A; Santini D; Tonini G; Vincenzi B
Oncology; 2020; 98(12):893-896. PubMed ID: 32818940
[TBL] [Abstract][Full Text] [Related]
9. ctcRbase: the gene expression database of circulating tumor cells and microemboli.
Zhao L; Wu X; Li T; Luo J; Dong D
Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32294193
[TBL] [Abstract][Full Text] [Related]
10. Analogous detection of circulating tumor cells using the AccuCyte
van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characterization of circulating tumor cells in triple negative breast cancer patients.
Agelaki S; Dragolia M; Markonanolaki H; Alkahtani S; Stournaras C; Georgoulias V; Kallergi G
Oncotarget; 2017 Jan; 8(3):5309-5322. PubMed ID: 28029660
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase expression in circulating tumor cells: a new tool to predict 5-fluorouracil resistance in metastatic colorectal cancer patients.
Abdallah EA; Fanelli MF; Buim ME; Machado Netto MC; Gasparini Junior JL; Souza E Silva V; Dettino AL; Mingues NB; Romero JV; Ocea LM; Rocha BM; Alves VS; Araújo DV; Chinen LT
Int J Cancer; 2015 Sep; 137(6):1397-405. PubMed ID: 25721610
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
14. Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients.
Payne RE; Yagüe E; Slade MJ; Apostolopoulos C; Jiao LR; Ward B; Coombes RC; Stebbing J
Pharmacogenomics; 2009 Jan; 10(1):51-7. PubMed ID: 19102715
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two detection systems for circulating tumor cells among patients with renal cell carcinoma.
Bai M; Zou B; Wang Z; Li P; Wang H; Ou Y; Cui K; Bian J; Li S; Xu X
Int Urol Nephrol; 2018 Oct; 50(10):1801-1809. PubMed ID: 30120680
[TBL] [Abstract][Full Text] [Related]
16. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
17. Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently.
Rot S; Taubert H; Bache M; Greither T; Würl P; Holzhausen HJ; Eckert AW; Vordermark D; Kappler M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513863
[TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor Cells in Desmoid Tumors: New Perspectives.
Braun AC; Campos FAB; Abdallah EA; Ruano APC; Medina TDS; Tariki MS; Pinto FFE; de Mello CAL; Chinen LTD
Front Oncol; 2021; 11():622626. PubMed ID: 34595102
[TBL] [Abstract][Full Text] [Related]
19. Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib.
Kalykaki A; Agelaki S; Kallergi G; Xyrafas A; Mavroudis D; Georgoulias V
Cancer Chemother Pharmacol; 2014 Apr; 73(4):685-93. PubMed ID: 24493157
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study.
Massard C; Oulhen M; Le Moulec S; Auger N; Foulon S; Abou-Lovergne A; Billiot F; Valent A; Marty V; Loriot Y; Fizazi K; Vielh P; Farace F
Oncotarget; 2016 Aug; 7(34):55069-55082. PubMed ID: 27391263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
